# Devalingam Mahalingam, M.D., Ph.D. – FDA Inspection, Oct 18, 2024

Source: https://www.keypedia.com/records/fda_inspections/devalingam-mahalingam-md-phd/24dfb723-1578-492f-ae7e-621f0dfd2a55
Source feed: FDA_Inspections

> FDA inspection 1252477 of Devalingam Mahalingam, M.D., Ph.D., October 18, 2024. Classification: Official Action Indicated (OAI). 2 citations under 21 CFR parts 50 and 312.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1252477
- Company Name: Devalingam Mahalingam, M.D., Ph.D.
- Inspection Date: 2024-10-18
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/muhammad-naiman/5c62c1ce-b6d3-424a-9738-f91b395bad46)
- [Company Rep](https://www.keypedia.com/people/vidhi-j-jani/2e8e2811-bcb6-49dc-8c36-bd3ed73874cf)
- [Company Rep](https://www.keypedia.com/people/yuanyuan-li/2043568b-a6ac-4f49-8018-c2c8edda8ac5)

Company: https://www.keypedia.com/companies/devalingam-mahalingam-md-phd/c4aa9219-b3c2-4842-a24f-cd02d1b4c5ad

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
